Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sanofi India has informed BSE that its Board of Directors will meet on Tuesday, 28 April 2026, to consider and approve the Unaudited Financial Results for the quarter ended 31 March 2026. This is a routine regulatory filing under SEBI's Listing Obligations, disclosing the upcoming board meeting date. The company has also confirmed that the trading window for insiders remains closed from 1 April 2026 to 30 April 2026 (both days inclusive), as already intimated on 24 March 2026. No financial numbers or business updates are provided in this filing.
This is a standard advance notice with no direct impact on shareholders or stock price. Investors should watch for the actual Q4 results announcement on or after 28 April 2026 for any meaningful performance signals.